$BRVO
Bravo Multinational Inc.

2023 Q2 Form 10-Q Financial Statement

#000109181823000067 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $73.84K $143.5K $147.2K
YoY Change -41.88% -2.57% 1.13%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $73.84K $143.5K $147.2K
YoY Change -41.88% -2.57% 1.13%
Operating Profit
YoY Change
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$73.84K $143.5K -$147.2K
YoY Change -41.88% -197.43% 1.07%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$73.84K -$143.5K -$147.2K
YoY Change -41.88% -2.57% 1.07%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$3.091K
COMMON SHARES
Basic Shares Outstanding 47.64M shares 47.64M shares 47.64M shares
Diluted Shares Outstanding 47.64M shares 47.64M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.540K $40.00 $60.00
YoY Change 8366.67% -33.33% -99.02%
Cash & Equivalents $2.540K $43.00 $60.00
Short-Term Investments
Other Short-Term Assets $29.33K $10.00
YoY Change -91.67%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.86K $43.00 $70.00
YoY Change 96445.45% -38.57% -98.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $31.86K $43.00 $70.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $31.86K $43.00 $70.00
YoY Change 96445.45% -38.57% -98.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.940K $2.210K $100.00
YoY Change 2135.0% 2110.0% -99.91%
Accrued Expenses $119.8K $1.656M $1.181M
YoY Change -90.79% 40.21% 67.26%
Deferred Revenue
YoY Change
Short-Term Debt $66.23K $216.8K $169.8K
YoY Change -62.73% 27.71% 37.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $230.7K $1.911M $1.387M
YoY Change -84.76% 37.8% 42.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $230.7K $1.911M $1.387M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $230.7K $1.911M $1.387M
YoY Change -84.76% 37.8% 42.77%
SHAREHOLDERS EQUITY
Retained Earnings -$91.08M
YoY Change
Common Stock $4.763K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$198.9K -$1.911M -$1.387M
YoY Change
Total Liabilities & Shareholders Equity $31.86K $43.00 $70.00
YoY Change 96445.45% -38.57% -98.88%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$73.84K -$143.5K -$147.2K
YoY Change -41.88% -2.57% 1.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$52.69K -$23.25K -$29.13K
YoY Change 559.45% -20.18% 35.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 55.18K $23.22K 29.10K
YoY Change 593.22% -20.2% 35.75%
NET CHANGE
Cash From Operating Activities -52.69K -$23.25K -29.13K
Cash From Investing Activities 0.000
Cash From Financing Activities 55.18K $23.22K 29.10K
Net Change In Cash 2.490K -$30.00 $0.00
YoY Change -8400.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$52.69K -$23.25K -$29.13K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47641010 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2023Q1 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
43 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
73 usd
CY2023Q1 us-gaap Assets
Assets
43 usd
CY2022Q4 us-gaap Assets
Assets
73 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2211 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
750 usd
CY2023Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2023Q1 brvo Due To Related Parties
DueToRelatedParties
216791 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1656167 usd
CY2023Q1 dei City Area Code
CityAreaCode
(757)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
306-6090
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock Par Value $0.0001
CY2023Q1 dei Trading Symbol
TradingSymbol
BRVO
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001444839
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2023Q1 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q1 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2022Q4 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-53505
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BRAVO MULTINATIONAL INCORPORATED
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4068651
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 230
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1537417 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1910969 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1767537 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89168493 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89168493 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91084182 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90940720 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1910926 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1767464 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1376 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2826 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
23336 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
25665 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
118750 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
118750 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
143462 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
147241 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
143462 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
147241 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
143462 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
147241 usd
CY2023Q1 brvo Weighted Average Number Of Common Shares Basic And Diluted In Shares
WeightedAverageNumberOfCommonSharesBasicAndDilutedInShares
47641010 shares
CY2022Q1 brvo Weighted Average Number Of Common Shares Basic And Diluted In Shares
WeightedAverageNumberOfCommonSharesBasicAndDilutedInShares
47641010 shares
CY2023Q1 brvo Net Loss Per Common Shares Basic And Diluted
NetLossPerCommonSharesBasicAndDiluted
-0.00
CY2022Q1 brvo Net Loss Per Common Shares Basic And Diluted
NetLossPerCommonSharesBasicAndDiluted
-0.00
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-143462 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-147241 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-30 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1461 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-666 usd
CY2023Q1 brvo Accrued Board Of Directors Fees
AccruedBoardOfDirectorsFees
118750 usd
CY2022Q1 brvo Accrued Board Of Directors Fees
AccruedBoardOfDirectorsFees
118750 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23251 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29127 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
23221 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29097 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23221 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29097 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-30 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-30 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1239506 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-147241 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1386747 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1767464 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-143462 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1910926 usd
CY2023Q1 brvo Net Royalty Percentage
NetRoyaltyPercentage
0.15 pure
CY2023Q1 us-gaap Area Of Land
AreaOfLand
76.63 acre
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zY4QbzKWu74i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zhyWbOyeIh4g">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023Q1 us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
42312 usd
CY2023Q1 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2022Q4 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2023Q1 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q1 brvo Due To Related Parties
DueToRelatedParties
216791 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q1 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2022Q1 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 brvo Shares Authorized
SharesAuthorized
1050000000 shares
CY2023Q1 brvo Rent Expense
RentExpense
0 usd
CY2022Q1 brvo Rent Expense
RentExpense
0 usd

Files In Submission

Name View Source Status
0001091818-23-000067-index-headers.html Edgar Link pending
0001091818-23-000067-index.html Edgar Link pending
0001091818-23-000067.txt Edgar Link pending
0001091818-23-000067-xbrl.zip Edgar Link pending
brvo-20230331.xsd Edgar Link pending
brvo20230331.htm Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
brvo-20230331_pre.xml Edgar Link unprocessable
brvo-20230331_def.xml Edgar Link unprocessable
brvo-20230331_cal.xml Edgar Link unprocessable
brvo20230331_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brvo-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable